Predictive Oncology Inc. announced that on May 18, 2022, Christina Jenkins, M.D. notified the company that she intends to resign as a director of the Company, effective August 31, 2022, in order to devote more time to her other business interests. Dr. Jenkins confirmed to the Company's board of directors that her resignation is not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +4.19% | +6.75% | -47.11% |
1st Jan change | Capi. | |
---|---|---|
-47.11% | 6.85M | |
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+5.48% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+18.07% | 25.32B |
- Stock Market
- Equities
- POAI Stock
- News Predictive Oncology Inc.
- Predictive Oncology Inc. Announces Christina Jenkins Intends to Resign as Director, Effective August 31, 2022